Results 251 to 260 of about 1,806,959 (282)
Some of the next articles are maybe not open access.

DNA Vaccination Techniques

2014
Multiple sclerosis (MS) is the most common inflammatory, demyelinating, and neurodegenerative disorder of the central nervous system (CNS) in humans. Although the etiology of MS remains unknown, several lines of evidence support the notion that autoimmunity against components of the myelin sheath plays a major role in susceptibility to and development ...
Nicolás, Fissolo   +2 more
openaire   +2 more sources

DNA Technology and Vaccines

International Journal of Technology Assessment in Health Care, 1994
AbstractIt has been 20 years since the concepts that are now embraced in the term recombinant DNA technology were first described. The technology has been used to design new vaccines, and one product — that for hepatitis B — has been in widespread use for almost a decade.
openaire   +2 more sources

Plasmid DNA Vaccines

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, 2001
Genes that code for the production of protein antigens have been cloned and recombined with plasmids. Gene-plasmid constructs have been amplified in a bacterial host, purified and administered to a mammalian host. The gene is expressed in the host and the antigen that is produced induces an immune response.
openaire   +2 more sources

Veterinary DNA Vaccines

2003
Vaccination has relied, in general, on two technologies for the production of antigenic material suitable for the generation of a protective immune response; live infectious agents and inactivated or subunit vaccine preparations. Live infectious agents generally are most efficacious, but there is always a risk factor when using this type of vaccine ...
S, van Drunen Littel-van den Hurk   +2 more
openaire   +2 more sources

Methods to improve the immunogenicity of plasmid DNA vaccines

Drug Discovery Today, 2021
Ângela Sousa   +2 more
exaly  

A brief review on DNA vaccines in the era of COVID-19

Future Virology, 2022
Massoud Saidijam   +2 more
exaly  

DNA vaccines against COVID-19: Perspectives and challenges

Life Sciences, 2021
Marcelo Mendonça   +1 more
exaly  

Next-Generation Vaccines: Nanoparticle-Mediated DNA and mRNA Delivery

Advanced Healthcare Materials, 2021
Xiaoyang Xu, Mingzhu Gao, Xue-Qing Zhang
exaly  

Human cancer virus vaccines

Ca-A Cancer Journal for Clinicians, 1974
Maurice R Hilleman
exaly  

Home - About - Disclaimer - Privacy